SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Hindustan Bio Sciences informs about outcome of board meeting

31 Oct 2025 Evaluate
Hindustan Bio Sciences has informed that pursuant to Regulation 30 and other applicable Regulations of SEBI (LODR), 2015, the Board of Directors of the Company in its meeting held today i.e., on October 81, 2025 approved the Un-Audited Standalone Financial Results of the company for the 5 Quarter ended on 30th September 2025 along with the Limited Review Report. The meeting commenced at 02:00 PM and concluded at 4.30 PM.

The above information is a part of company’s filings submitted to BSE.

Hind Bio Science Share Price

9.24 0.44 (5.00%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×